Drug Testing Locations - Epping, NH

Drug Testing in Epping, NH

Epping, New Hampshire Statistics

In 2022, Rockingham County's drug overdose death rate reached 17.5 per 100,000 residents.

Epping reported a 15% increase in drug-related emergency room visits in 2023.

Rockingham County witnessed a 12% rise in opioid-related arrests in 2022.

Epping has seen a 10% increase in drug treatment facility enrollments since 2022.

The NH Department of Health reported a decrease in heroin use by 8% in Epping.

In 2022, 25% of high school seniors in Epping admitted to using illicit drugs.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Epping, NH & Drug Testing Policies

Employers in Epping, NH, have been proactive in implementing drug-free workplace programs. Many businesses conduct random drug testing to ensure a safe and productive environment. This aligns with state guidelines encouraging safe workplace practices.

The state's New Hampshire Employment Security agency offers resources to businesses looking to develop comprehensive drug policies. Employers are encouraged to offer support to employees struggling with addiction.

Epping's business community frequently participates in substance abuse prevention workshops. These initiatives are designed to foster a supportive work environment and to connect employees with local resources for help and recovery.

Government Efforts with Drug Problems in Epping, NH

The town of Epping, NH, along with Rockingham County, has implemented several initiatives to combat drug abuse. The county has collaborated with state health officials to improve access to rehabilitation services and mental health support. Federal grants have also been utilized to enhance local law enforcement efforts.

Epping's government works closely with the New Hampshire Department of Health and Human Services to run educational campaigns targeting youth. The aim is to reduce initial drug exposure and to promote awareness about the dangers of substance abuse.

Local Drug Busts & News in Epping, NH

In 2023, Epping authorities conducted a large-scale drug bust, confiscating significant quantities of opioids. The operation resulted in multiple arrests and highlighted the collaborative efforts between local law enforcement and federal agencies.

Community events in Epping focusing on drug education have increased in frequency. These events often feature speakers from the New Hampshire Department of Justice, who emphasize the importance of community involvement in combating drug issues.

Local law enforcement continues to hold town hall meetings, discussing the latest trends in drug trafficking and abuse patterns. These meetings also serve as a platform for residents to voice concerns and propose solutions.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Epping, NH. Trusted by employers nationwide for accurate results and exceptional service.

New Hampshire DOT/Non DOT Physicals

New Hampshire Vision Tests

New Hampshire Audiograms

New Hampshire Respirator Fit Tests

New Hampshire Lift Tests

New Hampshire Background Checks

Clinical Testing Services

TB Testing in NH

Diabetes Testing in NH

Infectious Disease Testing in NH

Sickle Cell Anemia Testing in NH

Women/Men's Health Testing in NH

Resources & Citations

New Hampshire Department of Health and Human Services

Recovery Restart, NH

The Phoenix New England

Granite Pathways

NH Treatment Locator

New England Center for Addiction and Recovery

SOS Recovery Community Organization

Headrest NH

Riverbend Community Mental Health

Drug Testing Near Epping, NH

Atkinson, NH

Plaistow, NH

Barrington, NH

Hampstead, NH

Durham, NH

Stratham, NH

Newmarket, NH

Exeter, NH

Newfields, NH

Kingston, NH

Raymond, NH

Frequently Asked Questions

Customer Reviews